Skip to main content

Table 1 Socio-demographic and clinical characteristics, and hazard ratios for MACCE and all-cause mortality (N = 145).

From: Patient-reported outcomes as predictors of 10-year survival in women after acute myocardial infarction

   

MACCE n = 52

All-cause mortality n = 59

 

n*

%

HR

p-value

HR

p-value

Socio-demographics:

      

Mean age in years (SD)

72 (5)

 

1.05

0.131

1.06

0.044

Cohabitation status

   

0.007

 

<0.001

   - Living alone

60

41

2.12

 

2.87

 

   - Cohabitation

85

59

(ref)

 

(ref)

 

Marital status

   

0.003

 

0.009

   - Divorced

7

5

4.57

0.007

3.20

0.036

   - Widowed

62

43

2.76

0.001

2.61

0.001

   - Unmarried

6

4

0.84

0.868

2.71

0.111

   - Married

68

48

(ref)

 

(ref)

 

Educational status

   

0.085

 

0.098

   - Elementary school

61

44

  

(ref)

 

   - Secondary school

41

29

1.09

0.804

1.29

0.441

   - High school and university/college

37

27

2.00

0.039

1.99

0.032

Clinical characteristics:

      

Risk factors of CAD

      

   - Mean total cholesterol, mmol/L (SD)

7.0 (1.4)

 

1.10

0.400

1.05

0.660

   - Hypertension

53

37

0.96

0.877

1.30

0.318

   - Diabetes mellitus

17

12

1.74

0.130

1.22

0.607

   - Overweight

42

39

0.90

0.740

1.14

0.665

   - Family history of CAD

59

68

1.85

0.152

2.06

0.115

   - Smoking habits

   

0.531

 

0.817

- Non smoker

68

55

1.24

0.528

1.16

0.674

- Ex-smoker

21

17

0.77

0.607

1.31

0.528

- Current smoker

34

28

(ref)

 

(ref)

 

Previous angina

62

45

1.27

0.397

1.23

0.441

Previous acute MI

32

23

1.09

0.788

1.11

0.734

Mean time since MI in months (SD) †

29 (16)

 

1.01

0.333

1.01

0.398

Disease severity

      

   - Mean max CK (SD)

1099 (1000)

 

1.00

0.540

1.00

0.744

   - Q in ECG

63

44

0.83

0.502

1.22

0.447

   - Left ventricular ejection fraction

   

0.108

 

0.012

- >60%

78

62

(ref)

 

(ref)

 

- 30-60%

45

36

0.97

0.926

1.19

0.568

- <30%

2

2

4.69

0.038

9.88

0.003

Mean creatinine, μmol/L (SD) ‡

92.5 (18.9)

 

1.07

0.386

1.18

0.028

Treatment during index MI

   

0.258

 

0.793

   - Medical treatment

92

66

0.43

0.164

1.99

0.497

   - Thrombolysis

43

31

0.35

0.100

1.95

0.517

   - PCI/CABG

4

3

(ref)

 

(ref)

 

Medication at discharge after index MI

      

   - Beta blockers

98

69

0.50

0.015

0.77

0.340

   - Calcium antagonists

18

13

0.47

0.199

1.11

0.789

   - ACE inhibitors

40

28

1.44

0.232

1.36

0.281

   - Diuretics

48

34

1.60

0.109

1.66

0.060

   - Digitalis

9

6

1.97

0.152

1.19

0.738

   - Antithrombotics

123

86

1.04

0.924

1.14

0.730

   - Lipid-lowering

26

18

1.05

0.899

0.71

0.360

   - Antidiabetics

12

8

1.96

0.100

1.03

0.955

  1. Significant results are shown in bold.
  2. *n varies between the different variables because of missing values. †Time from index MI to survey. ‡Logtransformed as independent variable, HR per 10% increase.
  3. MACCE, major adverse cardiac and cerebral events; CAD, coronary artery disease; CK, creatinine kinase; PCI, percutaneous coronary intervention; CABG, coronary artery bypass grafting.
Back to article page

Health and Quality of Life Outcomes

ISSN: 1477-7525

Contact us